United States · Who invested in Visiogen?
Visiogen's investors include Novartis Venture Fund, CMEA Ventures, New Leaf Venture Partners, Three Arch Partners and Prospect Venture Partners, and 2 more on record.
United States · Series D startup
Who invested in Visiogen
One round we have observed, with the 7 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$40Mraised across 1 round since 2009, from 1 source
- Latest round
- Series D, $40MMay 2009
- Investors
- 7
The rounds
- May 2009Series D$40M
Novartis Venture Fund
CMEA Ventures
New Leaf Venture Partners- Three Arch Partners
Prospect Venture Partners- Technology Partners
- Foundation Medical Partners
Reported by onbiovc.comSEC filing: $20M sold, first sale Apr 2009
The exit
ExitBuyerPriceWhen
From historical deal records. Wrong? Tell us.
Everyone who backed them
Three Arch PartnersGrowth equity1round
Technology PartnersHedge fund1round
Foundation Medical PartnersPrivate equity1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Visiogen
How much has Visiogen raised?
Visiogen has raised $40M across 1 round since 2009.
When did Visiogen last raise?
Visiogen's most recent round was a Series D of $40M in May 2009.
What was Visiogen's biggest round?
Its most recent round, $40M in May 2009, is also its largest on record.
Who backed Visiogen first?
Visiogen's first round on record, in May 2009, was backed by Novartis Venture Fund, CMEA Ventures and New Leaf Venture Partners and 4 others.
What stage is Visiogen at?
Visiogen's latest named round is a Series D, in May 2009.
Where is Visiogen based?
Visiogen is based in the United States.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.